Endotoxin Activity Assay levels correlate with the microbiological results of Gram-negative organisms in septic patients by TSUNODA M et al.
Endotoxin Activity Assay levels correlate with
the microbiological results of Gram-negative
organisms in septic patients
著者名 TSUNODA M, KANG M, SAITO M, SAITO N, NAMIKI M,










Effects of mesenchymal stromal cells on human umbilical vein
endothelial cells in in vitro sepsis models.
K Lund1*, J Peltzer1, F Montespan1, N Oru2, E Vicaut2, J Duranteau3,
J-J Lataillade1
1Unité de Thérapie Cellulaire et Réparation Tissulaire, Institut de Recherche
Biomédicale des Armées/Centre de Transfusion Sanguine des Armées,
Clamart, France; 2Laboratoire d’étude de la microcirculation, Université Paris -
Diderot, Paris, France; 3Service d’Anesthésie-Réanimation Chirurgicale, Centre
Hospitalier Universitaire de Bicêtre, Le Kremlin-Bicêtre, France
Critical Care 2014, 18(Suppl 2):P72; doi:10.1186/cc14075
Introduction: Septic shock is a medical emergency that, despite the
medical advances that have been made, still remains a major cause of
hospital deaths. Cell therapy is an innovative field of research that could
provide a therapy for sepsis. Mesenchymal stromal cells (MSC) are
promising in cell therapy and more importantly for sepsis because of
their immunosuppressive capabilities [1]. MSC have been shown by
several groups to have a positive effect against sepsis in vivo [2-4]. It has
been predicted that the MSC interact with macrophage to release IL-10
that in turns reduces inflammation [4]. Other groups have focused on the
use of stimulated MSC to ameliorate their immunosuppressive capabilities
[5]. The main stimulation of MSC has been the use of inflammatory
stimulants like IFNg. Our work focuses on the identification of effective
MSC donors, whether primed with IFNg or naïve, and the development of
in vitro models that will predict how an MSC donor will act in vivo. We
also want to eliminate the use of cells completely and use their secreted
microvesicles as a therapy. The hypothesis is that the in vitro models will
eliminate a noneffective MSC donor and allow us to identify the MSC
donor that will have the greatest effect.
Methods: We developed two in vitro models that are similar to what
happens in vivo with WBC as they circulate in a septic patient. The first test
is the adherence of WBC to a layer of HUVECs in the presence of MSC or
microvesicles. The second is a permeability test to determine MSC ability
to block the permeability of a HUVEC layer.
Results: Our preliminary results have shown that we are able to identify,
using our two in vitro models, which MSC donor would be an effective
MSC for cell therapy.
Conclusion: MSC and their paracrine factors have to the potential to be
an effective therapy for sepsis, but one needs to identify an effective
donor before use in cell therapy.
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Introduction: The Endotoxin Activity Assay (EAA™; Spectral Diagnostics Inc.,
Toronto, Canada) is a useful diagnostic test for sepsis due to Gram-negative
infection and is based on the reaction of neutrophils to endotoxin
complexed with an anti-endotoxin antibody. However, the relations
between values of EAA and microbiological data have not been elucidated.
Our hypothesis is that EAA values correlate to the results of microbiological
cultures and also severity.
Methods: From July 2008 to July 2013, all adult patients with suspected
sepsis admitted to our medico-surgical ICU in whom EAA was measured
were included in this study. Data collected included age, gender, ICU
mortality, white blood cell (WBC) count, C-reactive protein (CRP),
procalcitonin (PCT), EAA levels, SOFA score and results of microbiological
culture. Patients with no microbiological data were excluded. Data were
analyzed by Kruskal-Wallis test, Mann-Whitney U test and multivariate
logistic regression. P < 0.05 was considered significant.
Results: Of 569 patients (353 men and 216 women; mean age 66.0 ±
17.4 years), 283 patients had Gram-negative infection and 286 patients
had no Gram-negative infection. Of 283 patients with Gram-negative
infection, 65 patients had Gram-negative organisms in blood. EAA levels
were significantly different between patients with Gram-negative blood,
in other infectious sites and no Gram-negative infection (0.45 ± 0.21 vs.
0.39 ± 0.17 vs. 0.36 ± 0.15, P = 0.03). The odds ratio (95% confidence
interval (CI)) of EAA levels for Gram-negative infection and Gram-negative
bacteremia were 3.89 (1.44 to 10.4) (P = 0.007) and 3.36 (2.16 to 40.6)
(P = 0.003), respectively. The odds ratio and CI of age and SOFA score for
ICU mortality were 1.03 (1.01 to 1.04) (P = 0.0003) and 1.33 (1.26 to 1.41)
(P < 0.0001), respectively, while gender, WBC, CRP, PCT and EAA levels
had no relations with ICU mortality. SOFA score was significantly higher
in patients with Gram-negative infection than in patients with no Gram-
negative infection (8.0 ± 4.6 vs. 6.7 ± 4.2, P = 0.0003).
Conclusion: EAA levels related to the detections of Gram-negative
organisms in cultures. Thus, a high EAA level may show the existence of
Gram-negative organisms in patients’ sites. EAA levels had relations with
SOFA score but no relations with ICU mortality.
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Introduction: The Endotoxin Activity Assay (EAA™; Spectral Diagnostics Inc.,
Toronto, Canada) is a rapid in vitro diagnostic test of the neutrophil reaction
to endotoxin and reflects the endotoxemia. A higher value of EAA (>0.60)
has been shown to correlate with developing severe sepsis and a high
mortality in other previous studies. We hypothesize that a value of EAA
more than 0.55, not >0.60, may be useful to earlier diagnose sepsis due to
Gram-negative organisms and to assess the severity.
Methods: The present study is a single-center retrospective observational
analysis of adult septic patients in whom EAA was performed from July 2008
to July 2013. Patients were divided into two groups: (1) EAA >0.55 and (2)
EAA < 0.54. Age, sex, days of ICU stay, ICU mortality, body temperature,
WBC, CRP, procalcitonin (PCT), SOFA score, and microbiological data were
compared between two groups. Values are expressed as mean ± SD. Data
were analyzed by chi-square test and Mann-Whitney U test. P < 0.05 was
considered significant. The sensitivity, specificity, positive predictive value
(PPV), negative predictive value (NPV) and odds ratio were also evaluated.
Results: Five hundred and ninety-four patients (377 men and 217 women;
mean age 65.0 ± 17.5 years) were studied. There were (1) 104 patients with
EAA >0.55 and (2) 490 patients with EAA < 0.54. ICU mortality (39.4 vs. 26.6
%, P = 0.01), PCT (17.2 ± 36.0 vs. 11.8 ± vs. 30.6 ng/ml, P = 0.04), SOFA score
(8.1 ± 4.9 vs. 6.2 ± 4.6, P = 0.04) and positive Gram-negative organisms in
cultures (57.7 vs. 45.5 %, P = 0.02) were significantly higher in group (1) than
group (2). Age, sex, body temperature, WBC and CRP were not significantly
different between two groups. Using detections of Gram-negative
organisms in cultures, the sensitivity, the specificity, the PPV and the NPV
were 22.1, 85.2, 57.7 and 54.6%, respectively. The odds ratio was 1.64.
Conclusion: ICU mortality and severity were higher in patients with EAA
>0.55 than in patients with EAA < 0.54. There is a possibility that an EAA
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